Print PDF

Commercializing Diagnostics in the Era of Precision Medicine

Presented by UCSF-CTSI Catalyst Awards
05.08.2015

8:30 a.m. - 10:00 a.m.

Genetech Hall
Byers Auditorium
UCSF Mission Bay
600 16th Street

Join the UCSF-CTSI Catalyst team and Sheppard Mullin for a panel discussion on development and commercialization of diagnostics in the exciting time of state and nation-wide initiatives on Precision Medicine and in current climate of investing, intellectual property law and reimbursement. The panelists include:

  • Wayne Brown, JD — Deputy General Counsel & Chief Intellectual Property Officer, Quest Diagnostics
  • Mitch Nelles, PhD — Chief Operating Officer, CareDx
  • Alex Nie, JD PhD — Special Counsel, Sheppard Mullin Richter & Hampton LLP
  • Kimberly Popovits — Chief Scientific Officer & President, Genomic Health
  • Amy Sehnert, MD — Senior Director of Clinical Affairs, Illumina
  • Phyllis Whiteley, PhD – Venture Partner, Mohr Davidow Ventures

Moderated by Linda McAllister, VP Scientific Affairs, Becton Dickinson Biosciences.

Breakfast is served at 8:30, panel discussion will start at 9:00.

Event is open to public. Please RSVP by May 6th.

LiveStream will be available — check back here for the link on May 7th.

Click here for more details and registration information.

Attorneys

Practice Areas

Industries

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.